Ardabil University of Medical Sciences Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Organization Overview

First Clinical Trial
2008
NCT00670475
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Ardabil University of Medical Sciences | Department of Pharmacology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran | Pharmacology Dept, Faculty of Medicine, ArdabilUMS | rheomatology clinic, faculty of medicine, ArdabilUMS | Rheomatology clinic, Faculty of Medicine, ArdabilUMS

Active Ingredients

Drugs in Phase 4 Trials (4)

chloroquine (1 trial)

chondroitin (1 trial)

glucosamine (1 trial)

prednisone (meticorten) (1 trial)

Drugs in Phase 2 Trials (2)

olive (2 trials)

piroxicam (feldene) (1 trial)

Drugs in Phase 1 Trials (1)

risperidone (risperdal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 2)

Low Back Pain (Phase 2)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7